Articles

• How tech plays a critical role in meeting upcoming DSCSA deadlines

  With less than a month to go until these new regulations take effect, even the most prepared companies will encounter stark realities.

• How did the FDA do in 2019? Tell us what you think!

  Take our ultra quick survey for a chance to be quoted in our December issue.

• How does the Purdue deal compare to the largest settlements in pharma history?

  Purdue Pharma is pushing for a massive settlement to deal with thousands of opioid-related lawsuits.

• How Novartis’ data manipulation case is a cautionary tale for transparency

  “Seeing something and saying something” can be applied to the life sciences when a lack of transparency could result in a company facing stiff regulatory action.